Table 3.
Postoperative Data
| Variables | Control Group (N = 44) |
Closed-loop Group (N = 45) |
Point Estimate (95% CI) |
P Value |
|---|---|---|---|---|
| Total fluid infusion at postoperative day 1 (ml) | 1,325 [400 to 2,638] | 1,625 [500 to 2,648] | 100 (−300 to 700) | 0.534 |
| Major complications, N (%) | ||||
| Patients with any major complications | 5 (11) | 2 (4) | −7 (−18 to 4) | 0.224 |
| Pulmonary embolism | 1 (2) | 0 (0) | −2 (−7 to 2) | 0.312 |
| Pulmonary edema | 1 (2) | 0 (0) | −2 (−7 to 2) | 0.312 |
| Pneumonia | 2 (5) | 0 (0) | −5 (−10 to 2) | 0.241 |
| Incidence of acute kidney injury* | 4 (9) | 2 (4) | −5 (−15 to 6) | 0.382 |
| 30-day mortality | 1 (2) | 1 (2) | 0 (−6 to 6) | 0.987 |
| 90-day mortality | 1 (2) | 1 (2) | 0 (−6 to 6) | 0.987 |
| Minor complications, N (%) | ||||
| Patients with any minor complications | 10 (23) | 11 (24) | 2 (−16 to 19) | 0.849 |
| Superficial wound infection | 1 (2) | 1 (2) | 0 (−6 to 6) | 0.987 |
| Urinary infection | 1 (2) | 0 (0) | −2 (−7 to 2) | 0.312 |
| Paralytic ileus | 1 (2) | 1 (2) | 0 (−6 to 6) | 0.987 |
| Postoperative confusion† | 2 (5) | 0 (0) | −5 (−10 to 2) | 0.241 |
| Posmiddleerative nausea and vomiting | 5 (11) | 7 (16) | 4 (−10 to 18) | 0.561 |
| Other infections | 3 (7) | 3 (7) | 0 (−11 to 10) | 0.977 |
| Hemoglobin at discharge (g · dl−1) | 11.7 ± 1.7 | 11.8 ± 2.1 | 0.1 (−0.8 to 0.9) | 0.892 |
| Creatinine at discharge (mg · dl−1) | 0.9 [0.7 to 1.0] | 0.8 [0.6 to 1.0] | −0.1 (−0.2 to 0) | 0.052 |
| Estimated glomerular filtration rate at discharge (ml · kg−2 · 1.73 m−2) | 85 [74 to 95] | 96 [80 to 103] | 8 (0 to 15) | 0.059 |
| Intensive care or postanesthesia care unit length of stay (h) | 6 [3 to 19] | 17 [4 to 19] | 1 (−1 to 3) | 0.419 |
| Hospital length of stay (day) | 4 [3 to 7] | 4 [3 to 8] | 1 (0 to 1) | 0.259 |
| 90-day readmission | 12 (27) | 11 (24) | −3 (−21 to 15) | 0.761 |
Data are presented as number and percentage, (%) or median [25th to 75th percentiles] or mean ± SD. Point estimates for group differences were estimated for Mann-Whitney U test as the median difference in the set of values representing all differences in pairings between the two groups.
Included Kidney Disease Improving Global Outcomes I to III.
Assessed by nurses in the postanesthesia care unit.